Tavaborole

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 62332-467
  • Package NDC 62332-467-04
  • Package NDC 62332-467-10
  • Application number ANDA212188
  • SPL ID d35e58d2-869d-40bf-a00e-296a9d3bb659
  • SPL set ID 22a6617b-d4b1-405e-901a-0b39a7b2837d
  • UNII K124A4EUQ3
  • RxCUI 1543177

What the source publishes

Labeler
Alembic Pharmaceuticals Inc.
Active ingredients
Tavaborole
Form
SOLUTION
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659
{
  "name": "Tavaborole",
  "splId": "d35e58d2-869d-40bf-a00e-296a9d3bb659",
  "labels": [
    {
      "setId": "22a6617b-d4b1-405e-901a-0b39a7b2837d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22a6617b-d4b1-405e-901a-0b39a7b2837d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22a6617b-d4b1-405e-901a-0b39a7b2837d"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "Alembic Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE, DROPPER in 1 CARTON (62332-467-04)  / 4 mL in 1 BOTTLE, DROPPER",
      "package_ndc": "62332-467-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201023"
    },
    {
      "sample": false,
      "description": "1 BOTTLE, DROPPER in 1 CARTON (62332-467-10)  / 10 mL in 1 BOTTLE, DROPPER",
      "package_ndc": "62332-467-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201023"
    }
  ],
  "productId": "62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION",
  "productNdc": "62332-467",
  "deaSchedule": null,
  "genericName": "Tavaborole",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TAVABOROLE",
      "strength": "43.5 mg/mL"
    }
  ],
  "applicationNumber": "ANDA212188",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20201023",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000191279",
      "N0000000150",
      "M0002832"
    ],
    "unii": [
      "K124A4EUQ3"
    ],
    "rxcui": [
      "1543177"
    ],
    "spl_set_id": [
      "22a6617b-d4b1-405e-901a-0b39a7b2837d"
    ],
    "pharm_class_cs": [
      "Boron Compounds [CS]"
    ],
    "pharm_class_epc": [
      "Oxaborole Antifungal [EPC]"
    ],
    "pharm_class_moa": [
      "Protein Synthesis Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Alembic Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659"